Plasmid303 offers the best analysis past cynicism.
People seem to forget that the companies that manufacture drugs indefinitely for people like Nova are usually not the ones who developed the drug.
There is economic incentive to delay a cure for the original R&D firm, but not conceal one indefinitely. By the time a pharmaceutical hits the market, the clock has been ticking on its patent throughout the approval process. Once the patent expires, the original company would have more incentive to release a completely new drug, cure or otherwise, rather than just lose out to the "generic" manufacturers.
People seem to forget that the companies that manufacture drugs indefinitely for people like Nova are usually not the ones who developed the drug.
There is economic incentive to delay a cure for the original R&D firm, but not conceal one indefinitely. By the time a pharmaceutical hits the market, the clock has been ticking on its patent throughout the approval process. Once the patent expires, the original company would have more incentive to release a completely new drug, cure or otherwise, rather than just lose out to the "generic" manufacturers.